Parallel Advisors’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2
| Closed | – | – | 3623 |
|
|
2022
Q3 | $0 | Buy |
+2
| New | +$110 | ﹤0.01% | 3635 |
|
|
2022
Q1 | – | Sell |
-409
| Closed | -$12K | – | 3409 |
|
|
2021
Q4 | $12K | Buy |
409
+9
| +2% | +$279 | ﹤0.01% | 2050 |
|
|
2021
Q3 | $10K | Hold |
400
| – | – | ﹤0.01% | 2099 |
|
|
2021
Q2 | $14K | Sell |
400
-25
| -6% | -$976 | ﹤0.01% | 1878 |
|
|
2021
Q1 | $17K | Sell |
425
-102
| -19% | -$4.69K | ﹤0.01% | 1684 |
|
|
2020
Q4 | $23K | Buy |
527
+127
| +32% | +$6.26K | ﹤0.01% | 1424 |
|
|
2020
Q3 | $22K | Hold |
400
| – | – | ﹤0.01% | 1408 |
|
|
2020
Q2 | $25K | Hold |
400
| – | – | ﹤0.01% | 1329 |
|
|
2020
Q1 | $20K | Sell |
400
-19
| -5% | -$1.27K | ﹤0.01% | 1320 |
|
|
2019
Q4 | $33K | Sell |
419
-81
| -16% | -$4.8K | ﹤0.01% | 1195 |
|
|
2019
Q3 | $24K | Sell |
500
-200
| -29% | -$10.4K | ﹤0.01% | 1286 |
|
|
2019
Q2 | $37K | Buy |
700
+200
| +40% | +$11.5K | ﹤0.01% | 1020 |
|
|
2019
Q1 | $26K | Hold |
500
| – | – | ﹤0.01% | 1111 |
|
|
2018
Q4 | $20K | Sell |
500
-200
| -29% | -$7.49K | ﹤0.01% | 1056 |
|
|
2018
Q3 | $27K | Hold |
700
| – | – | ﹤0.01% | 1042 |
|
|
2018
Q2 | $31K | Hold |
700
| – | – | ﹤0.01% | 901 |
|
|
2018
Q1 | $34K | Sell |
700
-400
| -36% | -$22.3K | 0.01% | 836 |
|
|
2017
Q4 | $43K | Hold |
1,100
| – | – | 0.01% | 752 |
|
|
2017
Q3 | $43K | Hold |
1,100
| – | – | 0.01% | 736 |
|
|
2017
Q2 | $29K | Hold |
1,100
| – | – | 0.01% | 874 |
|
|
2017
Q1 | $33K | Sell |
1,100
-150
| -12% | -$3.78K | 0.01% | 782 |
|
|
2016
Q4 | $18K | Buy |
+1,250
| New | +$22K | ﹤0.01% | 907 |
|
Other funds holding GBT
Parallel Advisors's GBT Position: Q4 2022 in Review
Parallel Advisors sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 2 shares.
Parallel Advisors first reported a position in GBT in Q4 2016 and held it in 22 quarters. The position peaked at $43K in Q4 2017. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Parallel Advisors reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Parallel Advisors sold 2 Global Blood Therapeutics, Inc. shares in Q4 2022.
- Parallel Advisors first reported a position in Global Blood Therapeutics, Inc. in Q4 2016 and held it in 22 quarters.
- Parallel Advisors's Global Blood Therapeutics, Inc. position peaked at $43K in Q4 2017.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Parallel Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.